{
    "title": "Bristol, Nektar to terminate melanoma therapy trials after study fails (March 14)",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10610805/Nektar-tumbles-melanoma-combo-therapy-trial-fails.html",
    "date": "2022-03-14",
    "keywords": [
        "bempegaldesleukin",
        "cash",
        "cancer",
        "combination",
        "therapy",
        "study",
        "melanoma",
        "nektar",
        "treatment",
        "end",
        "march",
        "monday",
        "latestage",
        "developer",
        "trading",
        "week",
        "brokerage",
        "oppenheimer",
        "worldwide",
        "drug",
        "spending",
        "company",
        "december",
        "plan",
        "goal",
        "runway",
        "balance",
        "president",
        "executive",
        "officer",
        "howard",
        "robin",
        "conference",
        "call",
        "firstline",
        "trial",
        "run",
        "bristol",
        "agreement",
        "survival",
        "reduction",
        "amount",
        "time",
        "combo",
        "comparison",
        "opdivo",
        "risk",
        "recurrence",
        "cell",
        "carcinoma",
        "bladder",
        "reporting",
        "leo",
        "bhanvi",
        "satija",
        "bengaluru",
        "editing",
        "shinjini",
        "ganguli",
        "anil",
        "dsilva"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}